Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First FDA-approved treatment for geographic atrophy ➤ FDA accepts NDA for presbyopia drop ➤ NDA for geographic atrophy drug accepted with priority review ➤ Study: 5-year visual field data with MIGS device ➤ ASCRS news and events
➤ FDA approves first pharmacologic treatment of ROP for preterm infants ➤ FDA accepts NDA for dilation reversal drop ➤ Phase 2b results for anti-VEGF agent for wet AMD ➤ Interim results for Phase 1 study evaluating hydrogel implant for retinal diseases ➤ Data from ongoing Phase 1/2 clinical trial of gene therapy for Leber congenital amaurosis ➤ ASCRS news and events
➤ FDA accepts NDA for dry eye treatment ➤ Phase 2 study moves forward for investigational ocular autoimmune therapy ➤ Fast-track designation granted for investigational retinitis pigmentosa treatment ➤ First-in-human feasibility study data from drug-eluting IOL platform ➤ Study identifies the ‘best approach’ for anti-VEGF therapy for diabetic retinopathy ➤ ASCRS news and events
➤ Clinical trial for new cataract surgery technology ➤ Topline results from Phase 2 trial investigating treatment for persistent corneal epithelial defect ➤ Update on sustained-release glaucoma implant and Glaukos cornea programs ➤ First patient enrolled in Phase 3 trial for presbyopia drop ➤ ASCRS news and events
➤ FDA approves NDA for IOP-lowering drug ➤ NDA submitted for presbyopia drop ➤ IND accepted for investigational treatment of persistent corneal epithelial defect ➤ Topline results from Phase 2 study of novel sedation drug for cataract surgery ➤ First patient enrolled in Phase 3 trial for investigational TED therapy ➤ Complimentary access to video journal ➤ ASCRS news and events
Constance Okeke, MD, is a wife, mother, surgeon, researcher, assistant professor, consultant, and a soon-to-be two-time book author. EyeWorld caught up with her to learn more about her latest written endeavor and get some insights on what the process of book writing is like for a busy ophthalmologist.
Glaucoma Editor Nathan Radcliffe, MD, spoke about EyeWorld’s approach to glaucoma management and introduced the new Glaucoma Editor, Manjool Shah, MD.
While glaucoma specialists are likely familiar with MicroPulse Laser Therapy (Iridex) as a non-incisional, non-pharmaceutical glaucoma therapy, two physicians called it an “ace up your sleeve” and one that can be adopted by any surgeon who treats glaucoma patients.
➤ FDA accepts NDA for pupil dilation spray ➤ NDA for new glaucoma drug accepted ➤ PMA application submitted to FDA for new IOL ➤ Data report: 12-month efficacy seen from single mechanical MGD treatment ➤ Acquisition of company developing drugs for rare ophthalmic diseases ➤ ASCRS news and events
Two physicians shared their reasons for and experiences with combining MIGS procedures.
Get the latest ophthalmology news delivered to your inbox every Friday.